A. G. P. Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $2.16
Alliance Global Partners Sticks to Its Buy Rating for OrganiGram Holdings (OGI)
Haywood Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.5
Analysts' Opinions Are Mixed on These Healthcare Stocks: Royalty Pharma (RPRX), Waters (WAT) and OrganiGram Holdings (OGI)
A. G. P. Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.1
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.18
Haywood Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $3
A. G. P. Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.95
Analysts Offer Insights on Healthcare Companies: UniQure (QURE), Nyxoah (NYXH) and OrganiGram Holdings (OGI)
Haywood Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Organigram Holdings Inc. Price Target Cut to C$3.15/Share From C$3.60 by Canaccord Genuity
Organigram Holdings Inc. Is Maintained at Speculative Buy by Canaccord Genuity
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Cuts Target Price to $2.22
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $2.62
Organigram Holdings Inc. Price Target Raised to C$3.60/Share From C$3.25 by Canaccord Genuity
Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
Organigram Holdings (TSE:OGI) Plunges With Plans to Enter US Market
Buy Rating Affirmed for OrganiGram Holdings Amid Strong Profit Margins and Strategic Market Positioning
Jefferies Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)